Upendra Kaul

Summary

Country: India

Publications

  1. pmc Perspective on coronary interventions & cardiac surgeries in India
    Upendra Kaul
    Escorts Heart Institute, New Delhi, India
    Indian J Med Res 132:543-8. 2010
  2. ncbi request reprint Angiographic follow-up of genous bioengineered stent in acute myocardial infarction (GENAMI)-a pilot study
    Upendra Kaul
    Fortis Hospitals, Vasant Kunj and NOIDA
    Indian Heart J 60:532-5. 2008
  3. ncbi request reprint Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study
    Upendra Kaul
    Department of Interventional Cardiology, Batra Hospital and Medical Research Centre, New Delhi, India
    Catheter Cardiovasc Interv 57:497-503. 2002
  4. ncbi request reprint Cobalt chromium stent with antiproliferative for restenosis trial in India (COSTAR I)
    Upendra Kaul
    Fortis Flt Lt Rajan Dhall Hospital, New Delhi, India
    Indian Heart J 59:165-72. 2007
  5. doi request reprint The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow up study
    Upendra Kaul
    Fortis Escorts Heart Institute and Research Centre, New Delhi, India Fortis Flt Lt Rajan Dhall Hospital, New Delhi, India Electronic address
    Indian Heart J 65:510-7. 2013
  6. doi request reprint Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients - interim results from multicenter post market surveillance registry in India
    Ashok Seth
    Escort Heart Institute, New Delhi, India
    Indian Heart J 65:586-92. 2013
  7. ncbi request reprint Evaluation of the XIENCE V everolimus eluting coronary stent system in the Asian population of the SPIRIT V single arm study. 2-year clinical follow-up data
    Upendra Kaul
    Escorts Heart Institute and Research Centre, New Delhi, India
    Indian Heart J 63:402-8. 2011
  8. doi request reprint Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey
    Upendra Kaul
    Fortis Flt Lt Rajan Dhall Hospital, Vasant Kunj, New Delhi, India
    Indian Heart J 64:54-9. 2012
  9. doi request reprint Fractional Flow Reserve: intracoronary versus intravenous adenosine induced maximal coronary hyperemia
    P S Sandhu
    Fortis Escorts Heart Institute and Research Center, Okhla Road, New Delhi, India
    Indian Heart J 65:147-51. 2013
  10. ncbi request reprint Air travel and pulmonary embolism: "economy class syndrome"
    Vineet Bhatia
    Escorts Heart Institute and Research Centre, Okhla Road, New Delhi, India
    Indian Heart J 60:608-11. 2008

Collaborators

Detail Information

Publications11

  1. pmc Perspective on coronary interventions & cardiac surgeries in India
    Upendra Kaul
    Escorts Heart Institute, New Delhi, India
    Indian J Med Res 132:543-8. 2010
    ..Indigenous research and scientific data acquisition in relation to the modern technology for achieving coronary revascularization has also started on a promising note...
  2. ncbi request reprint Angiographic follow-up of genous bioengineered stent in acute myocardial infarction (GENAMI)-a pilot study
    Upendra Kaul
    Fortis Hospitals, Vasant Kunj and NOIDA
    Indian Heart J 60:532-5. 2008
    ..GENAMI, an angiographic follow-up study was undertaken to evaluate the safety and efficacy of a new generation endothelial progenitor cell (EPC) capture stent, GENOUS during primary angioplasty for ST-elevation myocardial infarction (MI)...
  3. ncbi request reprint Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study
    Upendra Kaul
    Department of Interventional Cardiology, Batra Hospital and Medical Research Centre, New Delhi, India
    Catheter Cardiovasc Interv 57:497-503. 2002
    ..However, these flows decline significantly before hospital discharge and lead to a high rate of SAT. The dosage and duration of infusion of eptifibatide in this setting needs further evaluation...
  4. ncbi request reprint Cobalt chromium stent with antiproliferative for restenosis trial in India (COSTAR I)
    Upendra Kaul
    Fortis Flt Lt Rajan Dhall Hospital, New Delhi, India
    Indian Heart J 59:165-72. 2007
    ....
  5. doi request reprint The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow up study
    Upendra Kaul
    Fortis Escorts Heart Institute and Research Centre, New Delhi, India Fortis Flt Lt Rajan Dhall Hospital, New Delhi, India Electronic address
    Indian Heart J 65:510-7. 2013
    ..Using the DCB followed by cobalt-chromium stent (CoCr) deployment or with a reverse sequence may yield different outcomes in terms of late loss...
  6. doi request reprint Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients - interim results from multicenter post market surveillance registry in India
    Ashok Seth
    Escort Heart Institute, New Delhi, India
    Indian Heart J 65:586-92. 2013
    ..The objective of this registry is to establish safety and efficacy of BioMatrix, BioMatrix™-Biolimus A9™ eluting stent in diabetic population in India...
  7. ncbi request reprint Evaluation of the XIENCE V everolimus eluting coronary stent system in the Asian population of the SPIRIT V single arm study. 2-year clinical follow-up data
    Upendra Kaul
    Escorts Heart Institute and Research Centre, New Delhi, India
    Indian Heart J 63:402-8. 2011
    ..As a significant proportion of the real world population in the SPIRIT V single arm study is Asian, the study provides insight into how this population responds to stenting with the XIENCE V Everolimus Eluting Coronary Stent (EES)...
  8. doi request reprint Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey
    Upendra Kaul
    Fortis Flt Lt Rajan Dhall Hospital, Vasant Kunj, New Delhi, India
    Indian Heart J 64:54-9. 2012
    ..The data so far suggests that ticagrelor has a wider applicability in usage in patients with ACS as compared to prasugrel. Prasugrel however seems to be better tolerated. Search is on for newer more potent but safer anti-platelet agents...
  9. doi request reprint Fractional Flow Reserve: intracoronary versus intravenous adenosine induced maximal coronary hyperemia
    P S Sandhu
    Fortis Escorts Heart Institute and Research Center, Okhla Road, New Delhi, India
    Indian Heart J 65:147-51. 2013
    ..IV route is time consuming, has more side effects and expensive. This study is undertaken to compare the two routes of administration...
  10. ncbi request reprint Air travel and pulmonary embolism: "economy class syndrome"
    Vineet Bhatia
    Escorts Heart Institute and Research Centre, Okhla Road, New Delhi, India
    Indian Heart J 60:608-11. 2008
    ..We present 3 cases who developed deep vein thrombosis (DVT) and subsequent pulmonary thromboembolism (PTE) after transatlantic air travel. The relevant literature is discussed...
  11. ncbi request reprint Coronary vasospasm presenting as Prinzmetals angina and life threatening Brady-arrhythmia independently at different times
    Aijaz H Mansoor
    Department of Cardiology, Escorts Heart Institute and Research Centre, New Delhi, India
    Indian Heart J 61:389-91. 2009
    ..Coronary angiography revealed evidence of reversible multi-vessel coronary spasm. Electrophysiological studies were normal. She was treated with nitrates and calcium blockers and a permanent pacemaker implantation...